Eikon Therapeutics has secured $350.7 million in Series D financing to advance its clinical stage programs and expand its pipeline. The latest funding round brings the company’s total private funding ...
President Donald Trump turned his attention to the Keystone XL Pipeline on Monday evening, calling for the company building it to "come back to America, and get it built — NOW!" Trump said he ...
The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced ...
Deep-pocketed investors have adopted a bullish approach towards Biogen (NASDAQ:BIIB), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Biogen Inc. (NASDAQ: BIIB ... The company is also focused on advancing its rare disease and immunology pipeline in 2025, which includes Phase 3 trials for Felzartamab, a treatment for multiple ...
The approval of Spinraza in 2016 and Qalsody in 2023 provided a solid foundation for Ionis' neurology pipeline. Partner Biogen's reported Spinraza revenue of roughly $2 billion annually in 2019-21 ...
Zorevunersen is intended for treating Dravet syndrome. Credit: Maks_lab/Shutterstock. Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat ...
Analysts project peak sales of $1.7 billion, although the path to reaching this figure may be gradual. Biogen's pipeline has faced setbacks, including the discontinuation of SAGE-324 for essential ...
A month after Biogen signaled plans to shift its attention to “external opportunities,” it delivered on that ambition. … ...
Seven explosive-packed drones on Monday hit a pumping station of the Caspian Pipeline Consortium, which carries Kazakh oil across southern Russia for export via the Black Sea, including to Europe. A ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果